PUBLICATIONS

Highlighted

Highlighted

Rapporto RIS-1/2021 - AR-ISS: National Antibiotic-Resistance Surveillance. Data 2020. Stefania Bellino, Simone Iacchini, Monica Monaco, Maria Del Grosso, Romina Camilli, Giulia Errico, Maria Giufrè, Sauro Sisi, Fortunato "Paolo" D'Ancona, Annalisa Pantosti, Patrizio Pezzotti, Patrizia Parodi


Istituto Superiore di Sanità
AR-ISS: National Antibiotic-Resistance Surveillance. Data 2020.
Stefania Bellino, Simone Iacchini, Monica Monaco, Maria Del Grosso, Romina Camilli, Giulia Errico, Maria Giufrè, Sauro Sisi, Fortunato "Paolo" D'Ancona, Annalisa Pantosti, Patrizio Pezzotti, Patrizia Parodi
2021, iii, 43 p. Rapporti ISS Sorveglianza RIS-1/2021 (in Italian)

The antibiotic-resistance surveillance system, coordinated by the Istituto Superiore di Sanità (the National Institute of Health in Italy) is an essential tool for studying and describing the emergence, the spread and the trend of antibiotic resistance in Italy. The surveillance system is based on a network of hospital laboratories present throughout the country, which send routine antibiotic susceptibility data for selected pathogens from invasive infections (blood or cerebrospinal fluid). The bacterial species under surveillance are 8: the Gram-positive species Staphylococcus aureus, Streptococcus pneumoniae, Enterococcus faecalis and Enterococcus faecium and the Gram-negative species Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter spp. The surveillance in Italy is essential to evaluate the resistance of specific pathogens to different classes of therapeutically relevant antibiotics, to study the spread of antibiotic-resistance in the country and to follow its trend over time. This report presents the results for the year 2020, at a time when the issue of antibiotic-resistance is intermingled with the SARS-CoV-2 pandemic, and the trend evaluation for 2015-2020.

Published 18/11/2021